Aida Pharmaceuticals, Inc.

AIDA · OTC
Analyze with AI
12/31/2007
12/31/2006
12/31/2005
12/31/2004
Operating Activities
Net Income$2,740$1,454$1,468
Dep. & Amort.$1,875$2,080$1,692
Deferred Tax-$56-$500$4
Stock-Based Comp.$0$0$0
Change in WC$2,144-$2,731$2,368
Other Non-Cash$1,689$2,358$589
Operating Cash Flow$8,392$2,660$6,121
Investing Activities
PP&E Inv.-$3,613-$2,968-$700
Net Acquisitions$104-$2,032-$937
Inv. Purchases-$9,341-$262-$561
Inv. Sales/Matur.$454$128$24
Other Inv. Act.$749$727-$2,582
Investing Cash Flow-$11,751-$4,406-$4,780
Financing Activities
Debt Repay.$3,921$4,453$501
Stock Issued$0$0$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$1,097$0-$1,666
Financing Cash Flow$5,018$4,453-$1,165
Forex Effect$623$280$144
Net Chg. in Cash$2,282$2,987$319
Supplemental Information
Beg. Cash$6,117$3,129$2,810
End Cash$8,399$6,117$3,129
Free Cash Flow$4,778-$308$5,420